"This is a blatant attempt at rent-seeking by an obvious vested interest. We know that the pharmaceutical industry has been lobbying hard to hamper the growth of e-cigarettes so it comes as no surprise to find Glaxo using the tired old gateway argument. The truth is that e-cigarettes will only "seriously disadvantage" the NRT market if they work better as quitting aids. In my experience—and the experience of countless other people—e-cigarettes are much better substitutes for smoking. If they were really a "gateway" to smoking, e-cigarettes would be good for companies like Glaxo as they would create more smokers (NRT companies need there to be smokers just as much as cigarette companies do)."

Certainly, Stan owes an apology to Jacob and he owes an apology to CATO as well.

The Rest of the Story

LAST：2014 new product factory price ecig vape pen exgo w2 ecigator ce4 |NEXT：2014 Rechargeable Ecigator Ecig V808D-3 electronic cigarette dubai with digital indicator